Please login to the form below

Not currently logged in
Email:
Password:

Affordable Care Act

This page shows the latest Affordable Care Act news and features for those working in and with pharma, biotech and healthcare.

Daily Brief

Daily Brief

Novartis says in a statement that it was seeking advice on how Trump might reform the Affordable Care Act, and paid Cohen’s firm $100, 000 a month for a year. ... We understand the need to make a profit – but this can be achieved by making the drugs

Latest news

  • After failing to repeal Obamacare, Trump tries another tack After failing to repeal Obamacare, Trump tries another tack

    Trump insists the order is “taking the first steps”towards repealing and replacing his predecessor’s Affordable Care Act, which he claimed has been blighted by “skyrocketing”premiums since it was ... No one can predict future health care needs

  • Xtandi slowdown weighs on Pfizer, but CEO won't move on M&A Xtandi slowdown weighs on Pfizer, but CEO won't move on M&A

    repeal of the Affordable Care Act (ACA) - it could be a much longer wait.

  • Loss aversion Loss aversion

    At a macro level this is true of the entire Affordable Care Act unto itself as Republicans are finding out. ... But it’s also true of the individual elements and clauses within the act itself.

  • Trump says House vote means Obamacare is Trump says House vote means Obamacare is "dead"

    The House of Representatives voted by 217 to 213 to pass the American Health Care Act, which marks the first legislative victory for the Trump administration and starts the ball rolling ... In a statement Trump said that the passage was effectively a

  • Being indifferent matters Being indifferent matters

    The new bill (dubbed the American Health Care Act) did not receive the requisite support from fellow Republicans because it was not viewed as enough of a departure from the Affordable ... Even though the bill was soundly rejected, there are many

More from news
Approximately 8 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Attracting doctors to low-demand specialties Attracting doctors to low-demand specialties

    patient care or, perhaps, the feeling that the field is dull or unfashionable. ... It can be speculated that the focus on primary care in the USA as a means of improving access to care (and as codified in the Affordable Care Act, also known

  • US health reforms US health reforms

    Most stakeholders in the US healthcare marketplace would prefer to see the Affordable Care Act survive ongoing efforts at repeal and replacement. ... Also, in the US, national law often begins life as state law, for example our recent federal Open

  • Massive uncertainty is the new norm Massive uncertainty is the new norm

    Some of the challenges. In the US, there is a new president who is yet to set out his policies, but he has made a commitment to repeal the Affordable Care ... Act. It seems highly likely that big pharma will be asked to subsidise some of that repeal.

  • Reaching new heights Reaching new heights

    The aspects were: patterns of use on a volume basis; distribution and trends in spending and the impact of transformative innovations on patient care. ... The impact of the Affordable Care Act (ACA) will continue to have an effect on medicine spending

  • The price is right? The price is right?

    Whatever the result, the Democrats' determination to prevent the Republican repeal of the Affordable Care Act will underscore political debate throughout 2016. ... The passing of Arzneimittelmarktneuordnungsgesetz (AMNOG), the Pharmaceutical Market

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Cytori appoints David Rickey as chairman Cytori appoints David Rickey as chairman

    According to Cytori, Dean requested the move to cope with Dignity Health's preparations for the implementation of the Affordable Care Act in the US in 2014. “

  • UCLA’s Eugene Washington joins J&J board UCLA’s Eugene Washington joins J&J board

    The Institute is a national research organisation authorised by Barack Obama's Patient Protection and Affordable Care Act to develop a comparative effectiveness research programme, which can be used to inform

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics